It exists as an injection (Ozempic for type 2 diabetes, Wegovy for weight management) and also as a pill (Rybelsus), FDA-approved since 2019 for type 2 diabetes
The 2003 WTO General Council Decision, later incorporated into Article 31bis of TRIPS, further expanded these flexibilities by enabling countries with insufficient pharmaceutical manufacturing capacity to import generic medicines produced under a compulsory license
Laloux L, Kastrati D, Cambier S, Gutleb AC, Schneider YJ (2020) The Food Matrix and the Gastrointestinal Fluids Alter the Features of Silver Nanoparticles
GLP-1 receptor agonists, such as Ozempic, Wegovy, Zepbound, and Mounjaro, often have monthly costs ranging from $150 to over $1,300 depending on insurance, dose and drug type